Showing 2151-2160 of 8180 results for "".
DermWireTV: Qwo Approved, Assessing Resident Anxiety
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-qwo-approved-assessing-resident-anxiety/19830/FDA has approved Qwo (collagenase clostridium histolyticum-aaes) from Endo, the first injectable treatment approved for moderate to severe cellulite in the buttocks of adult women. A recent survey offers perspective on anxiety among third-year dermatology residents in light of the COVID crisis. AlleVitiligo: Current and Future Developments
https://practicaldermatology.com/conferences/maui-derm-2020/vitiligo-current-and-future-developments/19722/John E. Harris, MD, PhD reviews treatment advances and emerging science in vitiligo. From new topical agents to intriguing studies on a potential role for biologics, there is very good reason to be optimistic about the future of vitiligo treatment.Counseling Patients on Their Future with Biologics
https://practicaldermatology.com/videos/dermatology-hub-neuroimmune-network/counseling-patients-on-their-future-with-biologics/57010/Practical Dermatology Editorial Board member Amy L. Spizuoco, DO, FAOCD, FAAD, describes the conversations she has with patients with atopic dermatitis who may be hesitant about remaining on a biologic treatment long-term.Analyzing the Overlap Between Atopic Dermatitis, Prurigo Nodularis, and Chronic Spontaneous Urticaria
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/analyzing-the-overlap-between-atopic-dermatitis-prurigo-nodularis-and-chronic-spontaneous-urticaria/50877/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Editorial Board member Jason E. Hawkes, MD, MS, FAAD, to discuss three different immune-mediated inflammatory skin conditions and how understanding their mechanisms can inform optimal treatment, based on the InternationalILDS Joins the Lancet Commission on Skin Health
https://practicaldermatology.com/series/skin-minute/ilds-joins-the-lancet-commission-on-skin-health/57085/Esther Freeman, MD, talks about the International League of Dermatologic Society (ILDS) and its new contributions to The Lancet’s new Commission focusing exclusively on skin health. It’s the first time the publication has devoted one of its highly regarded Commissions on skin health.Scientifically Speaking: Nanopulse Stimulation with Darrin Uecker
https://practicaldermatology.com/topics/skin-cancer-photoprotection/scientifically-speaking-nanopulse-stimulation-with-darrin-uecker/20111/The CellFX system from Pulse Biosciences is a true platform technology, says President/CEO Darrin Uecker. He talks to host Joel L. Cohen, MD about the technology, its application, and potential future uses.Vaser Shape
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/vaser-shape/19451/A description on the benefits of using VaserShape for reducing the appearance of cellulite along with a demonstration of the non-invasive ultrasound and massage therapy treatment.Where Does Phototherapy Still Fit In?
https://practicaldermatology.com/programs/dermatology-hub-neuroimmune-network/where-does-phototherapy-still-fit-in/48783/Christopher Bunick, MD, FAAD, discusses the situations in which phototherapy can still be useful in the age of advanced systemic therapies.What Should Dermatology PAs Look For in a Contract
https://practicaldermatology.com/series/pa-perspectives/what-should-dermatology-pas-look-contract/24164/In this video, Andrew Mastro, MS, PA-C, a board-certified physician assistant (PA) at the Illinois Dermatology Institute in Chicago, shares insights into what dermatology PAs should think about for their employment contracts (particularly when starting out at their first practice). Some of the topicDermWireTV: Minoxidil Shortage; SDPA Conference Coverage; Psoriasis Pipeline Update; Expert Insights on Cabtreo
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-minoxidil-shortage-sdpa-conference-coverage-psoriasis-pipeline-update-expert-insights-on-cabtreo/20225/There's a shortage of available minoxidil in the Washington, DC, area according to newly published data. Study author Adam Friedman, MD, of George Washington University, shares his thoughts on how this shortage--and other drug shortages--might be avoided in the future. At the 21st SDPA Annual Confer